UBS has reaffirmed its buy recommendation for Capgemini, raising the price target to €220 from €210, indicating a potential upside of 36%. Despite losing market share and a challenging outlook for the first half of the year, the company anticipates a return to growth in the latter half. For 2025, Capgemini aims for sales growth of -2% to +2%, an operating margin of 13.3% to 13.5%, and organic free cash flow of approximately €1.9 billion.